Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myoma

Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myoma - Goserelin trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026073

Enrollment

Registered

2017-02-13

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, myoma

Interventions

goserelin acetate injection 3 times every 4 weeks goserelin acetate injection 6 times every 4 weeks

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients with endometriosis and uterine myoma premenopausal women

Exclusion criteria

Exclusion criteria: pregnant patient severe clinical complication (ex.cancer) patients who were desired for emergent operation unknown genital bleeding

Design outcomes

Primary

Measure	Time frame
Change of diameter of uterine myoma (measured by MRI) before and after administration	—

Secondary

Measure	Time frame
Changes of VAS score Chages of serum FSH, LH and estradil	—

Countries

Japan

Contacts

Public ContactShozo Yoshida

Nara Medical University Department of Obstetrics and Gynecology

syoshida1208@gmail.com0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026